TScan Therapeutics, Inc. (TCRX)

NASDAQ: TCRX · Real-Time Price · USD

1.260

+0.050 (4.13%)

At close: May 8, 2026, 4:00 PM EDT

1.300

+0.040 (3.17%)

After-hours: May 8, 2026, 7:45 PM EDT

TScan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	128.06	152.41	178.69	133.36	120.03	161.41
Short-Term Investments	-	-	111.42	58.69	-	-
Cash & Short-Term Investments	128.06	152.41	290.11	192.04	120.03	161.41
Cash Growth	-49.12%	-47.47%	51.06%	60.00%	-25.64%	363.93%
Other Current Assets	4.71	4.8	2.61	2.19	4.1	4.25
Total Current Assets	132.77	157.21	292.72	194.24	124.13	165.65
Net Property, Plant & Equipment	64.13	66.45	71.6	71.23	69.2	17.26
Other Long-Term Assets	5.1	5.13	6.8	6.68	5.76	5.2
Total Assets	201.99	228.79	371.12	272.15	199.09	188.11
Accounts Payable	2.3	1.24	4.28	2.37	2.91	1.77
Accrued Expenses	8.59	7.67	15.41	10.72	6.84	6.52
Current Portion of Long-Term Debt	-	-	-	3.35	-	-
Current Portion of Leases	7.44	7.17	4.57	3.25	3.68	1.65
Unearned Revenue	1.64	2.62	11.7	10.14	3.87	11.41
Total Current Liabilities	19.97	18.7	35.96	29.82	17.31	21.34
Long-Term Debt	32.65	32.53	32.07	26.7	29.29	-
Long-Term Leases	52.45	54.44	60.74	59.14	53.01	4.39
Other Long-Term Liabilities	-	-	1.38	5.62	0.05	1.59
Total Long-Term Liabilities	85.1	86.97	94.19	91.46	82.35	5.99
Total Liabilities	105.07	105.67	130.15	121.28	99.66	27.33
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	630.44	627.98	616.01	398.46	257.81	252.93
Accumulated Other Comprehensive Income	-	-	0.05	-	-	-
Retained Earnings	-	-504.86	-375.1	-247.6	-158.38	-92.16
Total Common Shareholders' Equity	96.92	123.12	240.97	150.87	99.43	160.78
Shareholders' Equity	96.92	123.12	240.97	150.87	99.43	160.78
Total Liabilities & Equity	201.99	228.79	371.12	272.15	199.09	188.11
Total Debt	92.54	94.14	97.38	92.43	85.98	6.04
Net Cash (Debt)	35.52	58.27	192.73	99.61	34.04	155.36
Net Cash Growth	-39.04%	-69.77%	93.48%	192.60%	-78.09%	467.91%
Net Cash Per Share	0.27	0.45	1.72	1.52	1.42	13.32
Book Value	96.92	123.12	240.97	150.87	99.43	160.78
Book Value Per Share	0.75	0.95	2.15	2.30	4.13	13.79
Tangible Book Value	96.92	123.12	240.97	150.87	99.43	160.78
Tangible Book Value Per Share	0.75	0.95	2.15	2.30	4.13	13.79

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q